| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contributions |
From the First Department of Internal Medicine (H.H., T. Inomata, Y.O., S.H., Y.O., M.K., Y.A.), Niigata University School of Medicine, Niigata, Japan, and the Department of Internal Medicine (T. Izumi), Kitasato University School of Medicine, Sagamihara, Japan.
Correspondence to Haruo Hanawa, MD, First Department of Internal Medicine, Niigata University School of Medicine, Asahi-machi 1-754, Niigata 951, Japan.
| Abstract |
|---|
|
|
|---|
heavy chain. Five of 12 rats receiving synthetic peptides developed
macroscopic signs of myocarditis. To examine T-cell receptor (TCR) Vß
expression and CDR3 of the TCR ß chain of lesion-infiltrating T cells
in EAM, total RNA was isolated from heart, pericardial effusion,
spleen, lymph node, and peripheral blood. TCR Vß
expression of the T cells infiltrating the lesions revealed a
predominance of Vß4. On the basis of single-strand conformation
polymorphism analysis for CDR3 of the TCR Vß4 chain,
heart and pericardial spaceinfiltrating T cells were considered to
be oligoclonal, whereas spleen, lymph node, and peripheral
blood in a rat with EAM and spleen in a native rat were considered to
be polyclonal. In the same rat, clonotypes of heart-infiltrating T
cells were almost the same as those of pericardial spaceinfiltrating
T cells. Furthermore, on sequence analysis for CDR3 of the TCR
Vß4 chain, the amino acid motifs were similar among T cells
infiltrating into lesions of different EAM rats. In the present
study, TCR ß chains of heart and pericardial spaceinfiltrating T
cells in EAM induced by synthesized peptide consisting of 17 amino
acids were examined. Vß4+ T cells with similar Vß CDR3 motifs that
infiltrate the heart and pericardial space may recognize the same
epitope.
Key Words: myocarditis T-cell receptor epitope cardiomyopathy immune system
| Introduction |
|---|
|
|
|---|
ßTCR antibody indicates the
important role of
ßT cells.6 7 8
ßT cells recognize antigenic peptides in the context of major
histocompatibility as a result of interaction of the peptide major
histocompatibility complex with the
and ß
chains.9 In the TCR
chain, CDR3 contacts the
NH2-terminal portion of the peptide, whereas the TCR ß chain contacts
the COOH-terminal portion of the peptide.10
A previous study has shown oligoclonal expansion of T cells in lesions from rats with EAM induced by rod cardiac myosin.11 These oligoclonal T cells may recognize specific antigens, release cytokines to initiate myocarditis, and activate macrophages that release NO to injure myocytes.12 13 More recently, it has become apparent that there are several epitopes of EAM in rod cardiac myosin.14 15 16 17 18 We indicated that the myocardiogenic epitopes in Lewis rats were located in the RDCB9 (residues 1070 to 1165) of the rod cardiac myosin and that a cryptic minor epitope may reside in S-1.17 On the other hand, a study by Wegmann et al18 demonstrated that epitopes in Lewis rat EAM were located in the CM1 (residues 1304 to 1320) and CM2 (residues 1539 to 1555) of the cardiac myosin.18 To identify CM peptides with myocarditogenic properties, Wegmann et al made use of a putative binding motif for the major histocompatibility class II molecule RT1.B1 in the rat. Because there are several epitopes of EAM in rod cardiac myosin, T cells in lesions from rats with EAM induced by rod cardiac myosin may recognize certain antigenic peptides. Such T cells may constitute groups that recognize different antigenic peptides. In the present study, we elucidate T-cell clonality in inflammatory lesions from rats with EAM induced by synthetic peptide CM2, which may be a single epitope.
| Materials and Methods |
|---|
|
|
|---|
Induction of EAM
N-terminal acetylated synthetic peptides corresponding
to aa 1539 to 1555 (CM2) of rat cardiac myosin
heavy chain were
constructed and purified by Sawady Technology Co. CM2 peptides were
dissolved in PBS at a concentration of 4 mg/mL and emulsified with an
equal volume of complete Freund's adjuvant supplemented with 10 mg/mL
of Mycobacterium tuberculosis H37RA (Difco). To produce
actively induced EAM, on day 0, rats received a single immunization at
4 subcutaneous sites on the foot with a total of 0.4 mL of emulsion for
each rat, thus yielding an immunizing dose of 800 µg of CM peptide
per rat.
RT-PCR Analysis of Vß Expression
Lymph nodes and spleen mononuclear cells were isolated by
forcing popliteal lymph node and spleen through a 200-gauge stainless
steel mesh. Red blood cells in the spleen cell preparation were lysed
in 0.17 mol/L Tris supplemented with 0.83%
NH4Cl. Mononuclear cells in
peripheral blood were isolated by Ficoll-Paque (Pharmacia)
density gradient centrifugation at 1000g for
20 minutes. Mononuclear cells in pericardial effusion were isolated
after hemolysis in 0.17 mol/L Tris supplemented with 0.83%
NH4Cl. Total RNA was isolated from heart, lymph
node, spleen, peripheral blood, and pericardial effusion by
acid guanidinium thiocyanatephenolchloroform extraction. cDNA was
synthesized from 10 µg of total RNA with a TCR Cß primer and murine
Moloney leukemia virus reverse transcriptase (GIBCO-BRL) in a final
volume of 20 µL. Vß-specific PCR products were generated with
AmpliTaq polymerase (Toyobo Co), 22 Vß-specific
primers,19 and the same Cß primer from 1 µL
of heart cDNA and 0.2 µL of lymph node, spleen,
peripheral blood, and pericardial effusion cDNA, according
to the following amplification profile: 30 cycles at 94°C for 60
seconds, 55°C for 90 seconds, and 72°C for 120 seconds. Amplified
products were separated on 3% agarose gels and stained with
ethidium bromide.
PCR Single-Strand Conformation Polymorphism
Amplified PCR products were diluted (2:3) in denaturing
solution (95% formamide, 10 mmol/L EDTA, 0.1% bromophenol blue,
and 0.1% xylene cyanol), heated at 96°C for 5 minutes, and then
cooled on ice for 10 minutes. The diluted sample (10 µL) was adjusted
to 50% glycerol, and 3 µL was subjected to single-strand
conformation polymorphism by electrophoresis on nondenaturing 5%
polyacrylamide (ratio of acrylamide to
bisacrylamide, 19:1) gel (14x14x0.1 cm) in 0.5x
Tris-borate-EDTA containing 10% glycerol at 14 V/cm for 5 hours at
room temperature. DNA fragments were detected with a silver staining
kit (Daiichi Chemical Co Ltd).20
Sequencing Analysis
For the purposes of cloning and sequencing, Vß-specific PCR
products were purified with microcon-100 (Amicon Inc) and directly
inserted into the pGEM-T vector (Promega). The recombinant plasmids
were then used to transform Escherichia coli JM109 competent
cells (Takara). Individual ampicillin-resistant colonies were
isolated, and the plasmid DNA was sequenced with a TaqDye
Deoxy terminator cycle sequencing kit and a DNA sequencer (model 373A
or 310, Applied Biosystems).
| Results |
|---|
|
|
|---|
RT-PCR Analysis of TCR Vß Expression
We compared TCR Vß expression in the heart and pericardial
effusion of the 3 rats with myocarditis on day 17 (early stage) and the
rat with myocarditis on day 20 with that of mononuclear cells from
normal rat spleen, because a marked bias toward the expression of
Vß8.2 was apparent early during the onset of experimental autoimmune
encephalomyelitis induced by guinea pig myelin basic protein in Lewis
rats.21 22 RNA was extracted from spotty
macroscopic white lesions in the hearts of EAM rats. PCR
analysis revealed that the expression of Vß4 genes in the
hearts and pericardial spaces of EAM rats was more apparent than the
expression in normal rat spleen (Figure 1
).
|
PCR Single-Strand Conformation Polymorphism Analysis of
TCR Vß4 Chain CDR3
The structure of PCR products corresponding to the CDR3 region
of the TCRß chain was examined by single-strand conformation
polymorphism analysis. Heterogeneous PCR
products corresponding to this region migrate as a smear on
single-strand conformation polymorphism analysis, whereas
homogeneous products migrate as
bands.23 Because Vß4 genes were the dominant
genes expressed in the hearts and pericardial spaces of EAM rats, we
examined TCR Vß4 chain CDR3. PCR products of TCR Vß4 chain from
normal spleen and from individual EAM heart and pericardial effusion on
day 17, 20, or 23 migrated as a single band on ethidium
bromidestained agarose gels (Figure 1
and data not shown). However,
on single-strand conformation polymorphism analysis, PCR
products from normal spleen produced a smear, whereas those from
EAM heart and pericardial effusion generated bands within a smear
(Figure 2
). This shows that oligoclonal T
cells expanded in inflammatory lesions in the heart and pericardial
effusion but not in normal spleen. Furthermore, the fact that the PCR
products from heart and pericardial effusion in the same EAM rat
generated the same bands indicates that the clonality of T cells was
the same in the heart and pericardial effusion.
|
We examined the TCR Vß4 chain CDR3 region from popliteal lymph node,
spleen, and peripheral blood of EAM rats by single-strand
conformation polymorphism analysis (Figure 3
). It was demonstrated that the cells
were polyclonal, unlike the T cells from the heart and pericardial
effusion. It demonstrated that oligoclonal T cells expanded only in
inflammatory lesions, such as those found in the heart and pericardial
effusion.
|
Sequence Analysis of TCR Vß4 Chain CDR3
CDR3 sequences of Vß4 c DNA from normal spleen revealed no
oligoclonal expansion (Figure 4
). In
contrast, their sequences of cDNA from 3 EAM hearts or pericardial
effusions on day 17 (Figure 5
), an EAM
heart on day 20 (Figure 6
), and an EAM
heart or pericardial effusion on day 23 (Figure 7
) revealed oligoclonal expansion. In
individual rats, their sequences of Vß4 cDNA from the heart were the
same as those from pericardial effusion. To sum up, single-strand
conformation polymorphism and sequence analysis indicated
that the same clones expanded in the heart and pericardial space.
Although these analyses in popliteal lymph node, spleen, and
peripheral blood of EAM rats showed polyclonality, some
cDNA clones were the same as those of inflammatory lesions of identical
EAM rats (Figure 8
). On the other hand,
CDR3 sequences of Vß4 cDNA from the hearts and pericardial spaces of
different EAM rats were similar. Seven amino acids of the Vß side of
CDR3 were compared with each of the cDNA clones, and cDNA clones
differing in <2 amino acid motifs were detected (Figures 5
, 6
, and 7
).
No such cDNA clones were found in normal spleen (Figure 4
).
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
ßT cells in EAM
induced by porcine rod cardiac myosin, and we also noted that the cDNA
encoding Vß CDR3 from inflammatory lesions of EAM contained more
restricted sequences than that from normal spleen. However, the
expression of the TCR ß chain V gene was not restricted at the site
of inflammation, and T cells with similar amino acid motifs of CDR3 did
not infiltrate into inflammatory lesions in different EAM rats. The
synthetic peptide used as the myocarditogenic antigen in the
present study consisted of 17 amino acids, and major
histocompatibility class II molecules are considered to bind peptide
antigen consisting of 15 to 18 amino acids24 ;
thus, this synthetic peptide is suspected to be a single
myocarditogenic epitope. We consider that in EAM induced by the single
myocarditogenic epitope, T cells do not respond to other epitopes in
rod cardiac myosin; therefore, infiltrating T cells have restricted V
ß gene usage with similar amino acid motifs of CDR3. It is interesting that the CDR3 sequences in hearts and pericardial spaces of individual EAM rats were the same; however, those of different EAM rats were not the same, but they were similar. We suppose that not one but several myocarditogenic T cells can respond to this synthetic peptide epitope. Therefore, in one EAM rat a few clones of myocarditogenic T cells may be activated, and in another EAM rat a few other clones of myocarditogenic T cells may be activated. T cell clones that were cultivated by the same antigenic peptide were reported to have different kinds of TCR with similar CDR3,25 and in recent studies, it was reported that contact with TCR and antigenic peptide in the context major histocompatibility was not strict and that a kind of T-cell clone could respond to several antigenic peptides.26 The present study is compatible with those reports.
Why pericardial effusion arises after immunization with a contractile protein such as myosin heavy chain or synthetic cardiac myosin is very interesting. In EAM, epicardial lesions are more severe than endocardial lesions. In a previous study,4 we showed that many inflammatory cells might infiltrate the heart from the pericardial space. Myocarditogenic T cells that are autoreactive to myosin heavy chain or synthetic cardiac myosin may make contact with antigen-presenting cells in the epicardial region, and T-cell proliferation may occur in the pericardial cavity.
Experimental autoimmune encephalomyelitis, which is similar to multiple sclerosis, is induced in susceptible animal strains by immunization with myelin basic protein. In Lewis rats, the recognition of myelin basic protein clones 68 to 88 is carried out by TCR homologous to Vß8.2, and myelin basic protein clones 87 to 99 are Vß6 specific.19 27 Restriction in TCR usage in pathogenic clones provided a rationale for therapies that prevented and reversed experimental autoimmune encephalomyelitis with Vß-specific monoclonal antibodies.29 The CDR3 of TCRß chains expressed by these clones shows similarities in rats with experimental autoimmune encephalomyelitis.24 26 Remarkably, T cells with the amino acid motif LRG in the CDR3 region are found in lesions produced by experimental autoimmune encephalomyelitis in the Lewis rat after immunization with myelin basic proteins 87 to 99 and in lesions of patients with multiple sclerosis who exhibit HLA DR2.19 30 T cell clones in Lewis rats and in patients with multiple sclerosis, which express this CDR3 motif, all have been reported to have specificity for myelin basic protein 87 to 99.19 30 If this is so, it is conceivable that a common therapy for multiple sclerosis and animal experimental autoimmune encephalomyelitis can be established.
Myocarditis and dilated cardiomyopathy in humans and in animal models has been studied intensively. Several viruses,30 31 32 33 34 especially coxsackievirus, are thought to cause human myocarditis or dilated cardiomyopathy, whereas genetic regulation in the host and the interplay between virus persistence and autoimmunity are speculated to produce the later phases of the disease.35 In the pathogenesis of myocarditis and dilated cardiomyopathy, cellular immune responses are considered to play an important role,36 37 and T cells within inflammatory lesions were reported to use a restricted TCR V region38 39 40 41 or TCR CDR3 region11 ; however, the mechanism of heart-specific T-cell responses is not yet clear.
B- and T-cell epitopes of myocarditis or dilated cardiomyopathy have been reported by other investigators.40 41 42 43 44 45 46 Recently, T-cell epitopes of mouse and rat T-cellmediated EAM were reported.14 15 16 17 18 If the epitope of animal EAM is also the epitope of human myocarditis or dilated cardiomyopathy (eg, myelin basic protein 87 to 99 of experimental autoimmune encephalomyelitis and multiple sclerosis), then the CDR3 of the TCR expressed by T-cell clones should show similarities in EAM and human myocarditis or dilated cardiomyopathy, and it is conceivable that a common therapy for human myocarditis or dilated cardiomyopathy and EAM can be established.
HLA class II (DR and DQ) antigens are suspected to be associated with dilated cardiomyopathy,47 48 and studies of HLA in dilated cardiomyopathy are now being undertaken. Recent immunological studies have characterized the motifs for peptide binding to major histocompatibility classes I and II.49 50 To elucidate the mechanism of myocarditis or dilated cardiomyopathy and establish specific immunotherapies, further studies are needed to clarify the relation between major histocompatibility of patients, pathogenic epitopes, and TCR of pathogenic T cells.
| Selected Abbreviations and Acronyms |
|---|
|
Received September 11, 1997; accepted April 27, 1998.
| References |
|---|
|
|
|---|
2. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:36303636.[Abstract]
3.
Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T,
Suzuki K, Shibata A. Rat dilated cardiomyopathy
after autoimmune giant cell myocarditis. Circ Res. 1994;75:278284.
4. Hanawa H, Tsuchida M, Matsumoto Y, Watanabe H, Abo T, Sekikawa H, Kodama M, Zhang S, Izumi T, Shibata A. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis: their similarity to extrathymic T cells in mice and the site of proliferation. J Immunol. 1993;150:56825695.[Abstract]
5. Kodama M, Zhang S, Hanawa H, Shibata A. Immunohistochemical characterization of infiltrating mononuclear cells in the rat heart with experimental autoimmune giant cell myocarditis. Clin Exp Immunol. 1992;90:330335.[Medline] [Order article via Infotrieve]
6.
Kodama M, Matsumoto Y, Fujiwara M. In vivo
lymphocyte-mediated myocardial injuries demonstrated by adoptive
transfer of experimental autoimmune myocarditis.
Circulation. 1992;85:19181926.
7. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol. 1991;147:21412147.[Abstract]
8.
Hanawa H, Kodama M, Inomata T, Izumi T, Shibata A,
Tuchida M, Matsumoto Y, Abo T. Anti-
ß T cell receptor
antibody prevents the progression of experimental autoimmune
myocarditis. Clin Exp Immunol. 1994;96:470475.[Medline]
[Order article via Infotrieve]
9. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395402.[Medline] [Order article via Infotrieve]
10.
Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden
BC, Ysern X, Kim JK, Shao X, Ward ES, Mariuzza RA. Crystal structure of
the V
domain of a T cell antigen receptor. Science. 1995;270:18211824.
11.
Hanawa H, Inomata T, Sekikawa H, Abo T, Kodama M, Izumi
T, Shibata A. Analysis of heart-infiltrating T-cell clonotypes
in experimental autoimmune myocarditis in rats. Circ Res. 1996;78:118125.
12. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson C, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol. 1997;29:491502.[Medline] [Order article via Infotrieve]
13.
Hirono S, Islam O, Nakazawa M, Yoshida Y, Kodama M,
Shibata A, Izumi T, Imai S. Expression of inducible nitric oxide
synthase in rat experimental autoimmune myocarditis with special
reference to changes in cardiac hemodynamics.
Circ Res. 1997;80:1120.
14.
Liao L, Sindhwani R, Leinwand L, Diamond B, Factor S.
Cardiac
-myosin heavy chains differ in their induction of
myocarditis: identification of pathogenic epitopes. J Clin
Invest. 1993;92:28772882.
15. Pummerer CL, Luze K, Grassl G, Bachmaier K, Offner F, Burrell SK, Lenz DM, Zamborelli TJ, Penninger JM, Neu N. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest. 1996;97:20572062.[Medline] [Order article via Infotrieve]
16.
Donermeyer DL, Beisel KW, Allen PM, Smith SC.
Myocarditis-inducing epitope of myosin binds constitutively and stably
to I-Ak on antigen-presenting cells in the heart. J Exp
Med. 1995;182:12911300.
17. Inomata T, Hanawa H, Miyanishi T, Yajima E, Nakayama S, Maita T, Kodama M, Izumi T, Shibata A, Abo T. Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ Res. 1995;76:726733.
18. Wegmann KW, Zhao W, Griffin AC, Hickey WF. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat: the utility of a class II binding motif in selecting self-reactive peptides. J Immunol. 1994;153:892900.[Abstract]
19. Gold DP, Vainiene M, Celnik B, Wiley S, Gibbs C, Hashim GA, Vandenbark AA, Offner H. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats, II: biased T cell receptor V ß expression predominates in spinal cord infiltrating T cells. J Immunol. 1992;148:17121717.[Abstract]
20. Hoshino S, Kimura A, Fukuda Y, Dohi K, Sasazuki T. Polymerase chain reactionsingle-strand conformation polymorphism analysis of polymorphism in DPA1 and DPB1 genes: a simple, economical, and rapid method for histocompatibility testing. Hum Immunol. 1992;33:98107.[Medline] [Order article via Infotrieve]
21. Offner H, Buenafe AC, Vainiene M, Celnik B, Weinberg AD, Gold DP, Hashim G, Vandenbark AA. Where, when, and how to detect biased expression of disease-relevant Vß genes in rats with experimental autoimmune encephalomyelitis. J Immunol. 1993;151:506517.[Abstract]
22. Tsuchida M, Matsumoto Y, Hirahara H, Hanawa H, Tomiyama K, Abo T. Preferential distribution of Vß8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis. Eur J Immunol. 1993;23:23992406.[Medline] [Order article via Infotrieve]
23.
Yamamoto K, Sakoda H, Nakajima T, Kato T, Okubo M, Dohi
M, Mizushima Y, Ito K, Nishioka K. Accumulation of multiple T cell
clonotypes in the synovial lesions of patients with rheumatoid
arthritis revealed by a novel clonality analysis. Int
Immunol. 1992;4:12191223.
24. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368:215221.[Medline] [Order article via Infotrieve]
25.
Yamamura T, Kondo T, Sakanaka S, Kozovska M, Geng TC,
Takahashi K, Tabira T. Analysis of T cell antigen receptors of
myelin basic protein specific T cells in SJL/J mice demonstrates an
alpha chain CDR3 motif associated with encephalitogenic T cells.
Int Immunol. 1994;6:947954.
26.
Udaka K, Wiesmuller KH, Kienle S, Jung G, Walden P.
Decrypting the structure of major histocompatibility complex class
I-restricted cytotoxic T lymphocyte epitopes with complex peptide
libraries. J Exp Med. 1995;181:20972108.
27.
Burns FR, Li XB, Shen N, Offner H, Chou YK, Vandenbark
AA, Heber-Katz E. Both rat and mouse T cell receptors specific for the
encephalitogenic determinant of myelin basic protein use similar V
and V ß chain genes even though the major histocompatibility
complex and encephalitogenic determinants being recognized are
different. J Exp Med. 1989;169:2739.
29.
Zaller DM, Osman G, Kanagawa O, Hood L. Prevention and
treatment of murine experimental allergic encephalomyelitis with T cell
receptor V ß-specific antibodies. J Exp Med. 1990;171:19431955.
30. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, et al. Selection for T-cell receptor V ß-D beta-J ß gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993;362:6870.[Medline] [Order article via Infotrieve]
31.
Gold DP, Offner H, Sun D, Wiley S, Vandenbark AA,
Wilson DB. Analysis of T cell receptor ß chains in Lewis
rats with experimental allergic encephalomyelitis: conserved
complementarity determining region 3. J Exp Med. 1991;174:14671476.
32. Weiss LM, Movahed LA, Billingham ME, Cleary ML. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol. 1991;138:497503.[Abstract]
33. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994;24:10251032.[Abstract]
34.
Matsumori A, Matoba Y, Sasayama S. Dilated
cardiomyopathy associated with hepatitis C virus
infection. Circulation. 1995;92:25192525.
35. Rose NR, Herskowitz A, Neumann DA. Autoimmunity in myocarditis: models and mechanisms. Clin Immunol Immunopathol. 1993;68:9599.
36. Badorff C, Noutsias M, Kuhl U, Schultheiss HP. Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol. 1997;29:429434.[Abstract]
37. Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiss HP. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol. 1996;54:117125.[Medline] [Order article via Infotrieve]
38.
Seko Y, Yagita H, Okumura K, Yazaki Y. T-cell receptor
V ß gene expression in infiltrating cells in murine hearts with
acute myocarditis caused by coxsackievirus B3. Circulation. 1994;89:21702175.
39.
Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M,
Kagawa N, Osada K, Suzuki S, Yagita H, Okumura K, Yazaki Y. Restricted
usage of T cell receptor V
-V ß genes in infiltrating cells
in the hearts of patients with acute myocarditis and dilated
cardiomyopathy. J Clin Invest. 1995;96:10351041.
40.
Seko Y, Yoshifumi E, Yagita H, Okumura K, Yazaki Y.
Restricted usage of T-cell receptor V
genes in infiltrating
cells in murine hearts with acute myocarditis caused by coxsackie virus
B3. J Pathol. 1996;178:330334.[Medline]
[Order article via Infotrieve]
41. Neu N, Pummerer C, Rieker T, Berger P. T cells in cardiac myosin-induced myocarditis. Clin Immunol Immunopathol. 1993;68:107110.[Medline] [Order article via Infotrieve]
42. Maisch B, Bauer E, Cirsi M, Kochsiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis: characterization and pathogenetic relevance. Circulation. 1993;87(suppl IV):IV-49IV-65.
43.
Schulze K, Becker BF, Schauer R, Schultheiss HP.
Antibodies to ADP-ATP carrieran autoantigen in myocarditis and
dilated cardiomyopathyimpair cardiac function.
Circulation. 1990;81:959969.
44. Neumann DA, Lane JR, LaFond-Walker A, Allen GS, Wulff SM, Herskowitz A, Rose NR. Heart-specific autoantibodies can be eluted from the hearts of Coxsackievirus B3-infected mice. Clin Exp Immunol. 1991;86:405412.[Medline] [Order article via Infotrieve]
45. Huber SA, Cunningham MW. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J Immunol. 1996;156:35283534.[Abstract]
46.
Cunningham MW, Antone SM, Gulizia JM, McManus BM,
Fischetti VA, Gauntt CJ. Cytotoxic and viral neutralizing antibodies
crossreact with streptococcal M protein, enteroviruses, and human
cardiac myosin. Proc Natl Acad Sci U S A. 1992;89:13201324.
47. Carlquist JF, Ward RH, Husebye D, Feolo M, Anderson JL. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;74:918920.[Medline] [Order article via Infotrieve]
48.
Carlquist JF, Menlove RL, Murray MB, O'Connell JB,
Anderson JL. HLA class II (DR and DQ) antigen associations in
idiopathic dilated cardiomyopathy: validation study
and meta-analysis of published HLA association studies.
Circulation. 1991;83:515522.
49. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 1993;74:197203.[Medline] [Order article via Infotrieve]
50.
Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J,
Valsasnini P, Nagy ZA, Sinigaglia F. Peptide binding specificity of
HLA-DR4 molecules: correlation with rheumatoid arthritis association.
J Exp Med. 1995;181:18471855.
51. Smith LR, Kono DH, Theofilopoulos AN. Complexity and sequence identification of 24 rat V beta genes. J Immunol. 1991;147:375379.[Abstract]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |